- Home
- OMH vs NCNA Comparison
OMH vs NCNA Comparison
Compare OMH & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- NCNA
- Stock Information
- Founded
- OMH 2015
- NCNA 1997
- Country
- OMH Singapore
- NCNA United Kingdom
- Employees
- OMH N/A
- NCNA N/A
- Industry
- OMH Real Estate
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- NCNA Health Care
- Exchange
- OMH Nasdaq
- NCNA Nasdaq
- Market Cap
- OMH 4.6M
- NCNA 4.5M
- IPO Year
- OMH 2023
- NCNA 2017
- Fundamental
- Price
- OMH $2.11
- NCNA $0.55
- Analyst Decision
- OMH Strong Buy
- NCNA Buy
- Analyst Count
- OMH 1
- NCNA 2
- Target Price
- OMH $15.00
- NCNA $25.00
- AVG Volume (30 Days)
- OMH 407.2K
- NCNA 143.6K
- Earning Date
- OMH 01-01-0001
- NCNA 05-15-2025
- Dividend Yield
- OMH N/A
- NCNA N/A
- EPS Growth
- OMH N/A
- NCNA N/A
- EPS
- OMH N/A
- NCNA N/A
- Revenue
- OMH $5,390,607.00
- NCNA N/A
- Revenue This Year
- OMH $102.52
- NCNA N/A
- Revenue Next Year
- OMH $37.92
- NCNA N/A
- P/E Ratio
- OMH N/A
- NCNA N/A
- Revenue Growth
- OMH 25.77
- NCNA N/A
- 52 Week Low
- OMH $0.25
- NCNA $0.69
- 52 Week High
- OMH $3.35
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- OMH 49.97
- NCNA 35.90
- Support Level
- OMH $1.99
- NCNA $0.71
- Resistance Level
- OMH $3.77
- NCNA $0.89
- Average True Range (ATR)
- OMH 0.43
- NCNA 0.09
- MACD
- OMH -0.05
- NCNA -0.02
- Stochastic Oscillator
- OMH 19.81
- NCNA 0.00
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.